The Temporal Importance of TNFα Expression in the Development of Diabetes

Alferink, 1998, Control of neonatal tolerance to tissue antigens by peripheral T cell trafficking, Science, 282, 1338, 10.1126/science.282.5392.1338

Asseman, 1999, An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation, J. Exp. Med., 7, 995, 10.1084/jem.190.7.995

Balasa, 1997, CD40 ligand-CD40 interactions are necessary for the initiation of insulitis and diabetes in nonobese diabetic mice, J. Immunol., 159, 4620, 10.4049/jimmunol.159.9.4620

Balasa, 1998, IL-10 impacts autoimmune diabetes via a CD8+ T cell pathway circumventing the requirement for CD4+ T and B lymphocytes, J. Immunol., 161, 4420, 10.4049/jimmunol.161.8.4420

Bradley, 1999, Islet-specific Th1, but not Th2, cells secrete multiple chemokines and promote a rapid induction of autoimmune diabetes, J. Immunol., 162, 2511, 10.4049/jimmunol.162.5.2511

Burkly, 1989, T-cell tolerance by clonal anergy in transgenic mice with non-lymphoid expression of MHC class II I-E, Nature, 342, 564, 10.1038/342564a0

Burkly, 1990, Tolerance in transgenic mice expressing major histocompatibility molecules extrathymically on pancreatic cells, Science, 248, 1364, 10.1126/science.1694042

Carlow, 1992, Peripheral tolerance through clonal deletion of mature CD4−CD8+ T cells, Int. Immunol., 4, 599, 10.1093/intimm/4.5.599

Chomczynski, 1987, Single-step method of RNA isolation by acid guanidine-phenol-chloroform extraction, Anal. Biochem., 162, 156, 10.1016/0003-2697(87)90021-2

Delovitch, 1997, The nonobese diabetic mouse as a model of autoimmune diabetes, Immunity, 7, 727, 10.1016/S1074-7613(00)80392-1

Ehl, 1998, Viral and bacterial infections interfere with peripheral tolerance induction and activate CD8+ T cells to cause immunopathology, J. Exp. Med., 5, 763, 10.1084/jem.187.5.763

Forsthuber, 1996, Induction of Th1 and Th2 immunity in neonatal mice, Science, 271, 1728, 10.1126/science.271.5256.1728

Furth, 1994, Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter, Proc. Natl. Acad. Sci. USA, 91, 9302, 10.1073/pnas.91.20.9302

Gallichan, 1999, Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse, J. Immunol., 163, 1696, 10.4049/jimmunol.163.3.1696

Gossen, 1992, Tight control of gene expression in mammalian cells by tetracycline-responsive promoters, Proc. Natl. Acad. Sci. USA, 89, 5547, 10.1073/pnas.89.12.5547

Gossen, 1995, Transcritional activation by tetracyclines in mammalian cells, Science, 268, 1766, 10.1126/science.7792603

Green, 1998, Local expression of TNFα in neonatal NOD mice promotes diabetes by enhancing presentation of islet antigens, Immunity, 9, 733, 10.1016/S1074-7613(00)80670-6

Green, 2000, Neonatal tumor necrosis factor α promotes diabetes in nonobese diabetic mice by CD154-independent antigen presentation to CD8+ T cells, J. Exp. Med., 191, 225, 10.1084/jem.191.2.225

Grewal, 1996, Local expression of transgene encoded TNFα in islets prevents autoimmune diabetes in nonobese diabetic (NOD) mice by preventing the development of auto-reactive islet-specific T cells, J. Exp. Med., 184, 1963, 10.1084/jem.184.5.1963

Guerder, 1994, The role of the T cell costimulator B7-1 in autoimmunity and the induction and maintenance of tolerance to peripheral antigen, Immunity, 1, 155, 10.1016/1074-7613(94)90109-0

Guerder, 1994, Costimulator B7-1 confers antigen-presenting-cell function to parenchymal tissue and in conjunction with tumor necrosis factor α leads to autoimmunity in transgenic mice, Proc. Natl. Acad. Sci. USA, 91, 5138, 10.1073/pnas.91.11.5138

Guerder, 1998, Autoimmunity without diabetes in transgenic mice expressing β cell-specific CD86, but not CD80, J. Immunol., 161, 2128, 10.4049/jimmunol.161.5.2128

Heath, 1998, Cross-tolerance, J. Exp. Med., 187, 1549, 10.1084/jem.187.10.1549

Herrath, 1995, Coexpression of B7-1 and viral (“self”) transgenes in pancreatic beta cells can break peripheral ignorance and lead to spontaneous autoimmune diabetes, Immunity, 3, 727, 10.1016/1074-7613(95)90062-4

Herrera, 1994, A CD8+ T-lymphocyte-mediated and CD4+ T-lymphocyte-independent autoimmune diabetes of early onset in transgenic mice, Diabetologia, 37, 1277, 10.1007/BF00399802

Herrera, 2000, A mouse CD8 T cell-mediated acute autoimmune diabetes independent of the perforin and Fas cytotoxic pathways, PNAS, 97, 279, 10.1073/pnas.97.1.279

Homann, 1999, Autoreactive CD4+ T cells protect from autoimmune diabetes via bystander suppression using the IL4/Stat6 pathway, Immunity, 11, 463, 10.1016/S1074-7613(00)80121-1

Hosken, 1995, The effect of antigen dose on CD4+ T helper cell phenotype development in a T cell receptor-alpha beta-transgenic model, J. Exp. Med., 182, 1579, 10.1084/jem.182.5.1579

Jacob, 1990, Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF), Proc. Natl. Acad. Sci. USA, 87, 968, 10.1073/pnas.87.3.968

Kurts, 1998, The peripheral deletion of autoreactive CD8+ T cells induced by cross-presentation of self-antigens involves signaling through CD95 (Fas, Apo-1), J. Exp. Med., 188, 415, 10.1084/jem.188.2.415

Kurts, 1998, Major histocompatibility complex class I-restricted cross-presentation is biased toward high dose antigen and those released during cellular destruction, J. Exp. Med., 188, 409, 10.1084/jem.188.2.409

Kurts, 1999, Signalling through CD30 protects against autoimmune diabetes mediated by CD8 T cells, Nature, 398, 341, 10.1038/18692

Kurts, 1999, CD8 T cell ignorance or tolerance to islet antigens depends on antigen dose, PNAS, 96, 12703, 10.1073/pnas.96.22.12703

Ohashi, 1991, Ablation of “tolerance” and induction of diabetes by virus infection in viral antigen transgenic mice, Cell, 65, 305, 10.1016/0092-8674(91)90164-T

Oldstone, 1991, Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model, Cell, 65, 319, 10.1016/0092-8674(91)90165-U

Picarella, 1993, Transgenic tumor necrosis factor (TNF)-α production in pancreatic islets leads to insulitis, not diabetes, J. Immunol., 150, 4136, 10.4049/jimmunol.150.9.4136

Read, 1998, CD38+CD45RB(low) CD4+ T cells, Eur. J. Immunol., 28, 3435, 10.1002/(SICI)1521-4141(199811)28:11<3435::AID-IMMU3435>3.0.CO;2-P

Reiner, 1993, Constructing polycompetitor cDNA for quantitative PCR, J. Immunol. Methods, 165, 37, 10.1016/0022-1759(93)90104-F

Ridge, 1996, Neonatal tolerance revisited, Science, 271, 1723, 10.1126/science.271.5256.1723

Sarzotti, 1996, Induction of protective CTL responses in newborn mice by a murine retrovirus, Science, 271, 1726, 10.1126/science.271.5256.1726

Shockett, 1996, Diverse strategies for tetracycline-regulated inducible gene expression, Proc. Natl. Acad. Sci. USA, 93, 5173, 10.1073/pnas.93.11.5173

Shockett, 1995, A modified tetracycline-regulated system provides autoregulatory, inducible gene expression in cultured cells and transgenic mice, Proc. Natl. Acad. Sci. USA, 92, 6522, 10.1073/pnas.92.14.6522

Suri-Payer, 1998, CD4+CD25+ T cells inhibit both the induction and effector function of autoregulatory T cell and represent a unique lineage of immunoregulatory cells, J. Immunol., 160, 1212, 10.4049/jimmunol.160.3.1212

Thornton, 1998, CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production, J. Exp. Med., 188, 287, 10.1084/jem.188.2.287

Thornton, 2000, Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific, J. Immunol., 164, 183, 10.4049/jimmunol.164.1.183

Tian, 1998, Infectious Th1 and Th2 autoimmunity in diabetes-prone mice, Immunol. Rev., 164, 119, 10.1111/j.1600-065X.1998.tb01214.x

Yang, 1994, Effect of tumor necrosis factor a on insulin-dependent diabetes mellitus in NOD mice. I. The early development of autoimmunity and the diabetogenic process, J. Exp. Med., 180, 995, 10.1084/jem.180.3.995